# 8-K filed: Kairos Pharma, LTD.

> sec 8k · VERIFIED · 2026-07-22

Filed: 2026-07-22 AccNo: 0001493152-26-034185 Size: 509 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

- Company: Kairos Pharma, LTD.
- Primary source: https://www.sec.gov/Archives/edgar/data/1962011/000149315226034185/0001493152-26-034185-index.htm

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.